Dropodex
Dexamethasone Phosphate 0.1% w/v Eye Drops
A preservative-free corticosteroid eye drop for the treatment of ocular inflammation following cataract surgery and other anterior segment inflammatory conditions.
Patient Information Leaflet (PIL) →
Prescription only medicine (POM). Available in the GB market only. This medicine requires a prescription from a qualified healthcare professional.
Overview
Preservative-free corticosteroid eye care
Dropodex is a preservative-free dexamethasone phosphate 0.1% ophthalmic solution. As a corticosteroid anti-inflammatory, it reduces ocular inflammation effectively while the preservative-free formulation protects the ocular surface during treatment.
It is indicated for use following cataract surgery and for other anterior segment inflammatory conditions where infection has been excluded.
Indications
Patient Benefits
- ›Inflammation of the cornea, conjunctiva and iris
- ›Inflammation of the connective tissue of the eye
- ›Hypersensitive reaction of the conjunctiva not responding to standard treatments
- ›Post-cataract surgery inflammation control
- ›Ocular inflammation where the eye is not infected
Technical & Regulatory
Product Details
| Active Ingredient | Dexamethasone Phosphate 0.1% w/v |
| Drug Class | Corticosteroid (steroid anti-inflammatory) |
| Preservative | None (preservative free) |
| Legal Category | POM (Prescription Only Medicine) |
| Market | GB only |
| MA Holder | Rayner Pharmaceuticals Limited, Worthing, UK |
Pharmacovigilance
Report adverse events: safety.rayner@apcerls.com
APCER: +44 800 0418 153 · Also via Yellow Card Scheme
Also in Eye Care
AEON Sodium Chloride & Catacrom
Complete the post-operative care pathway with our OTC eye drop range.
Important Notice
Dropodex is a prescription-only medicine (POM) available in the GB market only. For professional use only. Marketing Authorisation Holder: Rayner Pharmaceuticals Limited, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ, UK. Rayner cannot offer medical advice to members of the public — for such advice consult a medical professional. Report adverse events via the Yellow Card Scheme or safety.rayner@apcerls.com.